CellKine clinical trial: first report from a phase 1 trial of allogeneic bone marrow-derived mesenchymal stem cells in subjects with painful lumbar facet joint arthropathy

• Published in: Pain reports Vol. 9; no. 5; p. e1181
• Main Authors: Yan, Dan, Zubair, Abba C., Osborne, Michael D., Pagan-Rosado, Robert, Stone, Jeffrey A., Lehman, Vance T., Durand, Nisha C., Kubrova, Eva, Wang, Zhen, Witter, Drew M., Baer, Meghan M., Ponce, Gabriela C., Quiñones-Hinojosa, Alfredo, Qu, Wenchun
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Wolters Kluwer 01.10.2024
• Subjects: Musculoskeletal; Research Paper; Musculoskeletal disorders; LFJA; Lumbar facet joint arthropathy; BM-MSCs; Low back pain; Pain management; Clinical trial; Bone marrow-derived mesenchymal stem cells; LBP; Bone marrow–derived mesenchymal stem cells

This report implies a positive outlook regarding the safety and feasibility of administering intra-articular allogeneic bone marrow-derived mesenchymal stem cells, along with potential therapeutic advantages for pain management and functional activities. AbstractBackground:Lumbar facet joint arthrop...